Search Ontology:
ChEBI
artemether
- Term ID
- CHEBI:195280
- Synonyms
-
- (1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
- (3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine
- 10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
- artemetero
- artemether
- artemetherum
- artemisininelactol methyl ether
- beta-artemether
- beta-dihydroartemisinin methyl ether
- dihydroartemisinin methyl ether
- methyl-dihydroartemisinine
- Definition
- An artemisinin derivative that is artemisinin in which the lactone has been converted to the corresponding lactol methyl ether. It is used in combination with lumefantrine as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.
- References
-
- Beilstein:6569878
- CAS:71963-77-4
- DrugBank:DB06697
- Drug_Central:245
- KEGG:D02483
- LINCS:LSM-5519
- PMID:11141088
- PMID:12781185
- PMID:16033274
- PMID:17242150
- PMID:17404003
- PMID:18243702
- PMID:3279208
- Wikipedia:Artemether
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from artemether
Phenotype where environments contain artemether
Phenotype modified by environments containing artemether
Human Disease Model